Cancer

Items 61-70 of 79

per page
Set Descending Direction
  1. anti-Podoplanin (human), mAb (18H5)
    AG-20T-0100
    AG-20T-0100-C100100 µg
    CHF 460.00
  2. anti-Podoplanin (mouse), mAb (RTD4E10)
    AG-20T-0101
    AG-20T-0101-C100100 µg
    CHF 460.00
  3. anti-Poly(ADP-ribose) [PAR], mAb (10H)
    AG-20T-0001
    AG-20T-0001-C05050 µg
    CHF 190.00
    AG-20T-0001-C100100 µg
    CHF 290.00
    AG-20T-0001-M0011 mg
    CHF 860.00
    anti-Poly(ADP-ribose) [PAR], mAb (10H)
  4. anti-Polyglutamate chain (polyE), pAb (IN105)
    AG-25B-0030
    AG-25B-0030-C05050 µg
    CHF 460.00
    Western blot analysis of protein polyglutamylation by anti-Polyglutamate chain (polyE), pAb (IN105) (Prod. No. AG-25B-0030).Method: HEK-293T cells are grown in standard culture conditions, transfected with plasmids expressing the tubulin glut
  5. anti-Polyglutamylation Modification, mAb (GT335)
    AG-20B-0020
    AG-20B-0020-C100100 µg
    CHF 495.00
    Western blot analysis of protein glutamylation with MAb to polyglutamylation modification (GT335) (Prod. No. AG-20B-0020).
Method: HeLa cells grown in standard culture conditions are lysed in SDS sample buffer and run on 10% SDS-PAGE. The pro
  6. anti-Polyglutamylation Modification, mAb (GT335) (Biotin)
    AG-20B-0020B
    AG-20B-0020B-C100100 µg
    CHF 530.00
  7. anti-Profilin, pAb (IG-706)
    AG-25T-0117
    AG-25T-0117-C01010 µg
    CHF 350.00
  8. anti-Progranulin (human), pAb
    AG-25A-0112
    AG-25A-0112-C100100 µg
    CHF 320.00
    Western blot analysis using anti-Progranulin (human), pAb (Prod. No. AG-25A-0112) at 1:2000 dilution. 1: Human Progranulin (FLAG®-tagged) (50ng). 2: Human Progranulin (tag-free) (100ng). 3: Human Granulin C (FLAG®
  9. anti-PROX1 (human), pAb
    AG-25T-0104
    AG-25T-0104-C100100 µg
    CHF 320.00
  10. anti-PROX1, pAb
    AG-25T-0105
    AG-25T-0105-C05050 µg
    CHF 350.00
    anti-PROX1, pAb

Items 61-70 of 79

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.